• DocumentCode
    2525792
  • Title

    The Study on Biotransformation of Paeonol and Interrelation with Cytochrome P450 Enzymes

  • Author

    Li Wen Lan ; Yang, Yang ; Ji Yubin ; Hu Zheng ting

  • Author_Institution
    Center of Res. on Life Sci. & Environ. Sci., Harbin Univ. of Commerce, Harbin, China
  • fYear
    2009
  • fDate
    11-13 June 2009
  • Firstpage
    1
  • Lastpage
    4
  • Abstract
    Objective: Metabolic enzymes and biotransformation of paeonol were studied by extraorgan incubation method in homogenized liver, and rational clinical administration method of paeonol was provided with scientific evidences. Methods: The content of surplus paeonol in the homogenized liver incubation solution was detected by HPLQ, and the effects of inductors and inhibitors in metabolism of paeonol were analyzed, besides metabolites and metabolic pathways of paeonol were investigated by HPLC/MS/MS . Results: The metabolic rate of paeonol in Dexamethasone (DEX) group which is the main CYP3A inductor, was significantly higher than it of the control group , however, the Phenobarbital (PB) group which is the main CYP2B inductor, had no significant difference in the metabolic rate of paeonol with control group ,moreover, Meletin, the specific CYP3A inhibitor, could significantly inhibit the metabolism of paeonol; the metabolites of paeonol in rat homogenized liver were 4-methoxyacetophenone-2-O-glucuronide and 2,4-dihydroxyacetophenone-5-O-sulphate. Conclusion: CYP3A is the main enzyme taking part in the biotransformation of paeonol in rats, and the paenol administrating simultaneously with the medicines, which have inducing and inhibiting effects on CYP3A, may probably have interactions.
  • Keywords
    biomedical materials; drug delivery systems; drugs; enzymes; liver; molecular biophysics; 2,4-dihydroxyacetophenone-5-O-sulphate; 4-methoxyacetophenone-2-O-glucuronide; CYP3A inductor; Dexamethasone group; Phenobarbital group; biotransformation; cytochrome P450 enzymes; extraorgan incubation method; homogenized liver; inhibiting effects; meletin; metabolic pathways; metabolites; paeonol; rat homogenized liver; rational clinical administration method; surplus paeonol; Biochemistry; Drugs; In vitro; Inductors; Inhibitors; Instruments; Liver; Pharmaceutical technology; Pumps; Temperature;
  • fLanguage
    English
  • Publisher
    ieee
  • Conference_Titel
    Bioinformatics and Biomedical Engineering , 2009. ICBBE 2009. 3rd International Conference on
  • Conference_Location
    Beijing
  • Print_ISBN
    978-1-4244-2901-1
  • Electronic_ISBN
    978-1-4244-2902-8
  • Type

    conf

  • DOI
    10.1109/ICBBE.2009.5163674
  • Filename
    5163674